Association of family history and other risk factors with breast cancer risk (Sweden)

Cancer Causes and Control

Volumn 9, Issue 3, 1998, Pages 259-267

  Magnusson, Cecilia ^a   Colditz, Graham ^b   Rosner, Bernard ^b   Bergström, Reinhold ^a,c   Persson, Ingemar ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c UPPSALA UNIVERSITY   (Sweden)

Author keywords

Breast neoplasms; Family history; Risk factors; Sweden; Women

Indexed keywords

ADULT; AGED; ARTICLE; BODY HEIGHT; BREAST CANCER; BREAST DISEASE; CASE CONTROL STUDY; CLINICAL TRIAL; CONTROLLED STUDY; FAMILY HISTORY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MENARCHE; MENOPAUSE; PRIORITY JOURNAL; QUESTIONNAIRE; RISK FACTOR; STATISTICS; SWEDEN; TELEPHONE;

AGED; BODY COMPOSITION; BREAST NEOPLASMS; CASE-CONTROL STUDIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MEDICAL HISTORY TAKING; MIDDLE AGED; ODDS RATIO; REPRODUCTION; RISK FACTORS; SWEDEN;

EID: 0031854195     PISSN: 09575243     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1008817018942     Document Type: Article

References (46)

1. Pharoah PDP, Day NE, Duffy S, Easton DF, Bruce AJP. Family history and the risk of breast cancer: A systematic review and meta-analysis. Int J Cancer 1997; 71: 800-9.
2. Brinton LA, Hoover R, Fraumeni JF Jr. Interaction of familial and hormonal risk factors for breast cancer. J Natl Cancer Inst 1982; 69: 817-22.
3. Bain C, Speizer FE, Rosner B, Belanger C, Hennekens CH. Family history of breast cancer as a risk indicator for the disease. Am J Epidemiol 1980;111: 301-8.
4. Farewell VT. The combined effects of breast cancer risk factors. Cancer 1977; 40: 931-6.
5. Dupont WD, Page DDL. Breast cancer risk associated with proliferative disease, age at first birth, and family history of breast cancer. Am J Epidemiol 1987; 125: 769-79.
6. Byrne C, Brinton LA, Haile LW, Schairer C. Heterogeneity of the effect of breast cancer. Epidemiology 1991; 2: 276-84.
7. Sellers TA, Kushi LH, Potter JD, et al. Effect of family history, body-fat distribution, and reproductive factors on the risk of postmenopausal breast cancer. N Engl J Med 1992; 326: 1323-9.
8. Haile RW, Witte JS, Ursin G, et al. A case-control study of reproductive variables, alcohol, and smoking in premenopausal bilateral breast cancer. Breast Cancer Res Treat 1996; 37: 49-56.
9. Andrieu N, Duffy SW, Rohan TE, et al. Familial risk, abortion and their interactive effect on the risk of breast cancer - a combined analysis of six case-control studies. Br J Cancer 1995; 72: 744-51.
10. Andrieu N, Clavel F, Auquier A, et al. Variations in the risk of breast cancer associated with family history of breast cancer according to age at onset and reproductive factors. J Clin Epidemiol 1993; 46: 973-80
11. Colditz GA, Rosner B, Speizer FE. Risk factors for breast cancer according to family history of breast cancer. J Natl Cancer Inst 1996; 88: 365-71.
12. Anderson DE, Badzioch MD. Combined effect of family history and reproductive factors on breast cancer risk. Cancer 1989; 63: 349-53.
13. McCredie M, Paul C, Skegg DCG, Williams S. Family history and risk of breast cancer in New Zealand. Int J Cancer 1997; 73: 503-7.
14. Must A, Willett WC, Dietz WH. Remote recall of childhood height, weight and body build by elderly subjects. Am J Epidemiol 1993; 138: 56-64
15. Breslow NE, Day NE. Statistical Methods in Cancer Research. Volume 1. The Analysis of Case-Control Studies. Lyon, France: International Agency for Research on Cancer, 1980
16. Floderus B, Mack TM. Recall bias in subjective reports of familial cancer. Epidemiology, 1990; 1: 318-21.
17. Colditz GA, Willett WC, Hunter DJ, et al. Family history, age and risk of breast cancer. Prospective data from the Nurses' Health Study [published erratum appears in JAMA 1993;270: 1548] [See comment citation in Medline]. JAMA 1993; 270: 338-43.
18. Calle EE, Martin LM, Thun MJ, Miracle HL, Heath CW Jr. Family history, age, and risk of fatal breast cancer. Am J Epidemiol 1993; 138: 675-81.
19. Ford D, Easton DF. The genetics of breast and ovarian cancer. Br J Cancer 1995; 72: 805-12.
20. Couch FJ, DeShano ML, Blackwood MA, et al. BRCA1 mutations in women attending clinics that evaluate the risk of breast cancer. N Engl J Med 1997; 336: 1409-15.
21. Miki Y, Swensen J, Shattuck-Eidens D, et al. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 1994; 266: 66-71.
22. Wooster R, Bignell G, Lancaster J, et al. Identification of the breast cancer susceptibility gene BRCA2. Nature 1995; 378: 789-92.
23. Johannsson O, Ostermeyer EA, Håkansson S, et al. Founding BRCA1 mutations in hereditary breast and ovarian cancer in southern Sweden. Am J Hum Genet 1996;58: 441-50.
24. Claus EB, Risch N, Thompson WD. Age at onset as an indicator of familial risk of breast cancer. Am J Epidemiol 1990; 131: 961-72.
25. Lynch HT, Conway T, Fitzgibbons R Jr, et al. Age-of-onset heterogeneity in hereditary breast cancer: minimal clues for diagnosis. Breast Cancer Res Treat 1988; 12: 275-85
26. Mettlin C, Croghan I, Natarajan N, Lane W. The association of age and familial risk in a case-control study of breast cancer. Am J Epidemiol 1990; 131: 973-83.
27. Schneider NR, Chaganti SR, German J, Chaganti RS. Familial predisposition to cancer and age at onset of disease in randomly selected cancer patients. Am J Hum Genet 1983; 35: 454-67.
28. Athma P, Rappaport R, Swift M. Molecular genotyping shows that ataxia-telangiectasia heterozygotes are predisposed to breast cancer. Cancer Genet Cytogenet 1996; 92: 130-4.
29. Breslow NE, Day NE. Statistical Methods in Cancer Research. Volume 2. The Design and Analysis of Cohort Studies. Lyon, France: International Agency for Research on Cancer, 1987.
30. Andrieu N, Demenais F. Interactions between genetic and reproductive factors in breast cancer risk in a French family sample. Am J Hum Genet 1997; 61: 678-90.
31. Magnusson C, Baron J, Persson I, et al. Body size in different periods of life and breast cancer risk in postmenopausal women. Int J Cancer (in press).
32. Ballard-Barbash R, Schatzkin A, Taylor P, Kahle LL. Association of change in body mass with breast cancer. Cancer Res 1990; 50: 2152-5.
33. London SJ, Colditz GA, Stampfer MJ, Willett WC, Rosner B, Speizer FE. Prospective study of relative weight, height and risk of breast cancer. JAMA 1989; 262: 2853-8.
34. Wing RR, Matthews KA, Kuller LH, Meilahn EN, Plantinga P. Waist to hip ratio in middle aged women. Associations with behavioral and psychosocial factors and with changes in cardiovascular risk factors. Arterioscler Thromb 1991; 11: 1250-7.
35. Le Marchand L, Kolonel LN, Earle ME, Mi MP. Body size at different periods of life and breast cancer risk. Am J Epidemiol 1988; 128: 137-52.
36. Brinton LA, Swanson CA. Height and weight at various ages and risk of breast cancer. Ann Epidemiol 1992; 2: 597-609.
37. Collaborative Group on Hormonal Factors in Breast Cancer. Breast cancer and hormonal contraceptives: collaborative reanalysis of individual data on 53,297 women with breast cancer and 100,239 women without breast cancer from 54 epidemiological studies. Lancet 1996; 347: 1713-27.
38. Stanford JL, Weiss NS, Voigt LF, Daling JR, Habel LA, Rossing MA. Combined estrogen and progestin hormone replacement therapy in relation to risk of breast cancer in middle-aged women. JAMA 1995;274: 137-42.
39. Schairer C, Byrne C, Keyle PM, Brinton LA, Sturgeon SR, Hoover RN. Menopausal estrogen and estrogen-progestin replacement therapy and risk of breast cancer United States. Cancer Causes Control 1994; 5: 491-500.
40. Newcomb PA, Longnecker MP, Storer BE, et al. Long-term hormone replacement therapy and risk of breast cancer in postmenopausal women. Am J Epidemiol 1995; 142: 788-95.
41. Collaborative Group on Hormonal Factors in Breast Cancer. Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52 705 women with breast cancer and 108 411 women without breast cancer. Lancet 1997; 350: 1047-59.
42. Dupont WD, Page DL. Menopausal estrogen replacement therapy and breast cancer. Arch Intern Med 1991; 151: 67-72.
43. Colditz GA, Egan KM, Stampfer MJ. Hormone replacement therapy and risk of breast cancer: results from epidemiologic studies. Am J Obstet Gynecol 1993; 168: 1473-80.
44. Brinton LA, Hoover R, Fraumeni JF Jr. Menopausal estrogens and breast cancer risk: An expanded case-control study. Br J Cancer 1986; 54: 825-32.
45. Mills PK, Beeson L, Phillips RL, Fraser GE. Prospective study of exogenous hormone use and breast cancer in Seventh-day Adventists. Cancer 1989; 64: 591-7.
46. Steinberg KK, Smith SJ, Thacker SB, Stroup DF. Breast cancer risk and duration of estrogen use: the role of study design in meta-analysis. Epidemiology 1994; 5: 415-21.